Kinomica

Kinomica has developed KScan, a phosphoproteomic diagnostic platform to help clinicians prescribe the right drug, for the right patient, at the right time.

Kinomica are a response-to-treatment company answering questions such as:

Of the drugs currently approved to treat a disease, which one is best for a particular patient?

For patients that don’t respond to treatment or relapse shortly afterwards, are there drugs approved for other diseases that may be beneficial?

How can phosphoproteomics help to develop better drugs?